The CAR-T cell therapy Aucatzyl was approved for relapsed or refractory B-cell precursor acute lymphoblastic leukemia based ...
Researchers found that neural crest stem cells are uniquely capable of reprogramming, challenging current reprogramming ...
FDA approves Autolus Therapeutics' Aucatzyl for adults with relapsed or refractory B-cell precursor acute lymphoblastic ...
The investigators added that inflammation and demyelination were reduced, while axonal density oligodendrocytes, ...
Hosted on MSN2d
New CAR T-Cell Therapy Approved for LeukemiaThe FDA approved obecabtagene autoleucel (obe-cel; Aucatzyl) for treating relapsed or refractory B-cell precursor acute ...
In both pediatric and adult patients, cranial radiation therapy causes a debilitating cognitive decline that is poorly understood and currently untreatable. This decline is characterized by ...
Interesting Engineering on MSN13d
Kesterite solar cells’ efficiency boosted with silver doping, defects reducedSolar cell technology has taken a significant leap with the introduction of silver-doping in kesterite (CZTSSe) thin-film ...
A team of molecular biologists and other medical specialists at Cold Spring Harbor Laboratory in New York, working with a ...
Tech Xplore on MSN15d
Next-generation solar cells become more powerful with silver-doping technologyA team of researchers has significantly improved the performance of kesterite (CZTSSe) thin-film solar cells. They developed ...
Direct reprogramming of one cell type to another may not be probabilistic, but deterministic, suggests a study focused on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback